On September 30, 2026, MEDIDECT signed a Memorandum of Understanding (MOU) with the Leading Research Center for Multimodal Contactless Sensing for Lifelog Applications (RLRC) during an official signing ceremony held in Daegu, South Korea.
The agreement aims to strengthen cooperation in clinical research, regulatory affairs, and the clinical application and commercialization of innovative contactless sensing technologies.
Through this partnership, MEDIDECT and the RLRC Research Center will explore opportunities for collaboration in the following areas:
- Clinical Development and Regulatory Consulting: Providing expertise in clinical trial planning and regulatory approval strategies for medical devices incorporating contactless sensing technologies.
- Clinical Trial Documentation: Supporting the preparation and review of clinical trial protocols and related regulatory documents.
- Clinical Research and Validation: Collaborating on clinical studies to evaluate the reliability, usability, and clinical applicability of emerging technologies.
- Research Collaboration: Promoting the exchange of expertise, resources, and knowledge to support research outcomes and technology commercialization.
This MOU represents an important step toward connecting innovative sensing technologies with practical clinical applications.
MEDIDECT looks forward to contributing its clinical development and regulatory expertise to support the advancement of innovative healthcare technologies.